| 臺大學術典藏 |
2020-09-30T03:22:31Z |
Use of hypoprothrombinemia-inducing cephalosporins and the risk of hemorrhagic events: A nationwide nested case-control study
|
Shen L.-J.; Wu F.-L.L.; Tsay W.; CHIEN-CHING HUNG; Lin S.-W.; Hsiao F.-Y.; Chen L.-J. |
| 臺大學術典藏 |
2020-09-29T01:47:40Z |
High incidences of invasive fungal infections in acute myeloid leukemia patients receiving induction chemotherapy without systemic antifungal prophylaxis: A prospective observational study in Taiwan
|
YEE-CHUN CHEN; Huang S.-Y.; Tsay W.; Tang J.-L.; Kung H.-C.; Lei W.-C.; Yao M.; Wu U.-I.; Hsu S.-C.; Lin C.-T.; Li C.-C.; Wu S.-J.; Hou H.-A.; Chou W.-C.; YEE-CHUN CHEN; Chang S.-C.; Ko B.-S.; Tien H.-F. |
| 臺大學術典藏 |
2020-08-06T07:52:01Z |
Bone marrow angiogenesis magnetic resonance imaging in patients with acute myeloid leukemia: Peak enhancement ratio is an independent predictor for overall survival
|
TIFFANY TING-FANG SHIH; Hou H.-A.; Liu C.-Y.; Chen B.-B.; Tang J.-L.; Chen H.-Y.; Wei S.-Y.; Yao M.; Huang S.-Y.; Yang P.-C.; Tien H.-F.; Hsu C.-Y.; Yu C.-W.; Chou W.-C.; Hsu S.-C.; Tsay W. |
| 臺大學術典藏 |
2020-07-09T02:57:05Z |
Bone marrow angiogenesis magnetic resonance imaging in patients with acute myeloid leukemia: Peak enhancement ratio is an independent predictor for overall survival
|
Shih T.T.-F.;Hou H.-A.;Liu C.-Y.;Chen B.-B.;Tang J.-L.;Chen H.-Y.;Wei S.-Y.;Yao M.;Huang S.-Y.;Chou W.-C.;Hsu S.-C.;Tsay W.;Chih-Wei Yu;Hsu C.-Y.;Tien H.-F.;Yang P.-C.; Shih T.T.-F.; Hou H.-A.; Liu C.-Y.; Chen B.-B.; Tang J.-L.; Chen H.-Y.; Wei S.-Y.; Yao M.; Huang S.-Y.; Chou W.-C.; Hsu S.-C.; Tsay W.; CHIH-WEI YU; Hsu C.-Y.; Tien H.-F.; Yang P.-C. |
| 臺大學術典藏 |
2020-06-22T07:37:17Z |
SOCSI methylation in patients with newly diagnosed acute myeloid leukemia
|
Chen C.-Y.;Tsay W.;Tang J.-L.;Shen H.-L.;Shu-Wha Lin;Huang S.-Y.;Yao M.;Chen Y.-C.;Shen M.-C.;Wang C.-H.;Tien H.-F.; Chen C.-Y.; Tsay W.; Tang J.-L.; Shen H.-L.; SHU-WHA LIN; Huang S.-Y.; Yao M.; Chen Y.-C.; Shen M.-C.; Wang C.-H.; Tien H.-F. |
| 臺大學術典藏 |
2020-06-16T07:53:43Z |
Characterization of CEBPA mutations in acute myeloid leukemia: Most patients with CEBPA mutations have biallelic mutations and show a distinct immunophenotype of the leukemic cells
|
Liang-In Lin;Chen C.-Y.;Lin D.-T.;Tsay W.;Tang J.-L.;Yeh Y.-C.;Shen H.-L.;Su F.-H.;Yao M.;Huang S.-Y.;Tien H.-F.; LIANG-IN LIN; Chen C.-Y.; Lin D.-T.; Tsay W.; Tang J.-L.; Yeh Y.-C.; Shen H.-L.; Su F.-H.; Yao M.; Huang S.-Y.; Tien H.-F. |
| 臺大學術典藏 |
2020-06-16T07:53:42Z |
Nucleophosmin mutations in de novo acute myeloid leukemia: The age-dependent incidences and the stability during disease evolution
|
Chou W.-C.;Tang J.-L.;Liang-In Lin;Yao M.;Tsay W.;Chen C.-Y.;Wu S.-J.;Huang C.-F.;Chiou R.-J.;Tseng M.-H.;Lin D.-T.;Lin K.-H.;Chen Y.-C.;Tien H.-F.; Chou W.-C.; Tang J.-L.; LIANG-IN LIN; Yao M.; Tsay W.; Chen C.-Y.; Wu S.-J.; Huang C.-F.; Chiou R.-J.; Tseng M.-H.; Lin D.-T.; Lin K.-H.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2020-06-16T07:53:42Z |
Acquisition of JAK2, PTPN11, and RAS mutations during disease progression in primary myelodysplastic syndrome [1]
|
Tien H.-F.;Lin D.-T.;Lin K.-H.;Chen Y.-C.;Ko B.-S.;Yao M.;Chiou R.-J.;Huang C.-F.;Yeh Y.-C.;Chang H.-H.;Tsay W.;Tang J.-L.;LIANG-IN LIN;Chen C.-Y.; Chen C.-Y.; LIANG-IN LIN; Tang J.-L.; Tsay W.; Chang H.-H.; Yeh Y.-C.; Huang C.-F.; Chiou R.-J.; Yao M.; Ko B.-S.; Chen Y.-C.; Lin K.-H.; Lin D.-T.; Tien H.-F. |
| 臺大學術典藏 |
2020-06-16T07:53:28Z |
Genetic alterations and their clinical implications in older patients with acute myeloid leukemia
|
Tsai C.-H.;Hou H.-A.;Tang J.-L.;Liu C.-Y.;Lin C.-C.;Chou W.-C.;Tseng M.-H.;Chiang Y.-C.;Kuo Y.-Y.;Liu M.-C.;Liu C.-W.;Liang-In Lin;Tsay W.;Yao M.;Li C.-C.;Huang S.-Y.;Ko B.-S.;Hsu S.-C.;Chen C.-Y.;Lin C.-T.;Wu S.-J.;Tien H.-F.; Tsai C.-H.; Hou H.-A.; Tang J.-L.; Liu C.-Y.; Lin C.-C.; Chou W.-C.; Tseng M.-H.; Chiang Y.-C.; Kuo Y.-Y.; Liu M.-C.; Liu C.-W.; LIANG-IN LIN; Tsay W.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Chen C.-Y.; Lin C.-T.; Wu S.-J.; Tien H.-F. |
| 臺大學術典藏 |
2020-06-16T07:53:25Z |
Prognostic impacts and dynamic changes of cohesin complex gene mutations in de novo acute myeloid leukemia
|
Tsai C.-H.;Hou H.-A.;Tang J.-L.;Kuo Y.-Y.;Chiu Y.-C.;Lin C.-C.;Liu C.-Y.;Tseng M.-H.;Lin T.-Y.;Liu M.-C.;Liu C.-W.;Liang-In Lin;Yao M.;Li C.-C.;Huang S.-Y.;Ko B.-S.;Hsu S.-C.;Lin C.-T.;Wu S.-J.;Chen C.-Y.;Tsay W.;Chuang E.Y.;Chou W.-C.;Tien H.-F.; Tsai C.-H.; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chiu Y.-C.; Lin C.-C.; Liu C.-Y.; Tseng M.-H.; Lin T.-Y.; Liu M.-C.; Liu C.-W.; LIANG-IN LIN; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Lin C.-T.; Wu S.-J.; Chen C.-Y.; Tsay W.; Chuang E.Y.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2020-06-16T07:53:24Z |
Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patients
|
Tien F.-M.;Hou H.-A.;Tsai C.-H.;Tang J.-L.;Chen C.-Y.;Kuo Y.-Y.;Li C.-C.;Lin C.-T.;Yao M.;Huang S.-Y.;Ko B.-S.;Hsu S.-C.;Wu S.-J.;Tsay W.;Tseng M.-H.;Liu M.-C.;Liu C.-W.;Liang-In Lin;Chou W.-C.;Tien H.-F.; Tien F.-M.; Hou H.-A.; Tsai C.-H.; Tang J.-L.; Chen C.-Y.; Kuo Y.-Y.; Li C.-C.; Lin C.-T.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; LIANG-IN LIN; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2020-06-16T07:53:23Z |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
Tien F.-M.;Hou H.-A.;Tang J.-L.;Kuo Y.-Y.;Chen C.-Y.;Tsai C.-H.;Yao M.;Lin C.-T.;Li C.-C.;Huang S.-Y.;Ko B.-S.;Hsu S.-C.;Wu S.-J.;Liu J.-H.;Chou S.-C.;Tsay W.;Tseng M.-H.;Liu M.-C.;Liu C.-W.;Liang-In Lin;Chou W.-C.;Tien H.-F.; Tien F.-M.; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Liu J.-H.; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; LIANG-IN LIN; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2020-05-26T09:27:36Z |
Autologous bone marrow transplantation for plasma cell leukemia: Report of a case
|
Chih-Hsin Yang;Lin M.-T;Tsay W;Liu L.T;Wang C.-H;Chen Y.-C.; CHIH-HSIN YANG; Lin M.-T; Tsay W; Liu L.T; Wang C.-H; Chen Y.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:35Z |
Long?�term disease?�free survival after autologous bone marrow transplantation in a primary plasma cell leukaemia: detection of minimal residual disease in the transplant marrow by third?�complementarity?�determining region?�specific probes
|
Yeh K.??H;Lin M.??T;Tang J.??L;Chih-Hsin Yang;Tsay W;Chen Y.??C.; Yeh K.?�H; Lin M.?�T; Tang J.?�L; CHIH-HSIN YANG; Tsay W; Chen Y.?�C. |
| 臺大學術典藏 |
2020-04-16T02:34:21Z |
Prognostic impacts and dynamic changes of cohesin complex gene mutations in de novo acute myeloid leukemia
|
Tsay, W.; Chen, C.-Y.; Yao, M.; Li, C.-C.; Huang, S.-Y.; Ko, B.-S.; Hsu, S.-C.; Lin, C.-T.; Wu, S.-J.; Lin, L.-I.; Liu, C.-W.; Tsai, C.-H.;Hou, H.-A.;Tang, J.-L.;Kuo, Y.-Y.;Chiu, Y.-C.;Lin, C.-C.;Liu, C.-Y.;Tseng, M.-H.;Lin, T.-Y.;Liu, M.-C.;Liu, C.-W.;Lin, L.-I.;Yao, M.;Li, C.-C.;Huang, S.-Y.;Ko, B.-S.;Hsu, S.-C.;Lin, C.-T.;Wu, S.-J.;Chen, C.-Y.;Tsay, W.;Chuang, E.Y.;Chou, W.-C.;Tien, H.-F.; Tsai, C.-H.; Hou, H.-A.; Tang, J.-L.; Kuo, Y.-Y.; Chiu, Y.-C.; Lin, C.-C.; Liu, C.-Y.; Tseng, M.-H.; Lin, T.-Y.; Liu, M.-C.; Chuang, E.Y.; Chou, W.-C.; Tien, H.-F.; ERIC YAO-YU CHUANG |
| 臺大學術典藏 |
2020-04-10T12:51:24Z |
Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies
|
Tsay W.; Huang S.-Y.; Yao M.; Chen Y.-C.; Shen M.-C.; Wang C.-H.; Tien H.-F.; Chiun Hsu; Chen C.-Y.; Tang J.-L.; Ko B.-S.; Huang T.-C.; Huang T.-C.;Ko B.-S.;Tang J.-L.;Chiun Hsu;Chen C.-Y.;Tsay W.;Huang S.-Y.;Yao M.;Chen Y.-C.;Shen M.-C.;Wang C.-H.;Tien H.-F. |
| 臺大學術典藏 |
2020-03-30T03:55:56Z |
Revision in reference ranges of peripheral total leukocyte count and diffential leukocyte percentages based on a normal serum C-reactive protein level
|
Huang Z.-S.;Shyh-Chyi Lo;Tsay W.;Hsu K.-L.;Chiang F.-T.; Huang Z.-S.; SHYH-CHYI LO; Tsay W.; Hsu K.-L.; Chiang F.-T. |
| 臺大學術典藏 |
2020-03-27T05:29:22Z |
Mycobacterial infections in adult patients with hematological malignancy
|
PO-REN HSUEH;Tien H.-F.;Tang J.-L.;Huang S.-Y.;Tsay W.;Huang Y.-T.;Liao C.-H.;Lai C.-C.;Sheng W.-H.;Chen C.-Y.; Chen C.-Y.; Sheng W.-H.; Lai C.-C.; Liao C.-H.; Huang Y.-T.; Tsay W.; Huang S.-Y.; Tang J.-L.; Tien H.-F.; PO-REN HSUEH |
| 臺大學術典藏 |
2020-03-27T05:29:16Z |
Clinical characteristics of candidaemia in adults with haematological malignancy, and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2001-2010
|
PO-REN HSUEH;Tien H.-F.;Chou W.-C.;Ko B.-S.;Tang J.-L.;Yao M.;Tsay W.;Huang S.-Y.;Chen C.-Y.; Chen C.-Y.; Huang S.-Y.; Tsay W.; Yao M.; Tang J.-L.; Ko B.-S.; Chou W.-C.; Tien H.-F.; PO-REN HSUEH |
| 臺大學術典藏 |
2020-03-27T05:29:07Z |
Clinical features of patients with infections caused by candida guilliermondii and candida fermentati and antifungal susceptibility of the isolates at a medical centre in taiwan, 2001-10
|
Chou W.-C.; Tien H.-F.; PO-REN HSUEH; Ko B.-S.; Yao M.; Tsay W.; Huang S.-Y.; Tang J.-L.; Chen C.-Y.; PO-REN HSUEH;Tien H.-F.;Chou W.-C.;Ko B.-S.;Yao M.;Tsay W.;Tang J.-L.;Huang S.-Y.;Chen C.-Y. |
| 臺大學術典藏 |
2020-03-27T05:28:58Z |
Clinical characteristics and treatment outcomes of patients with candidaemia due to Candida parapsilosis sensu lato species at a medical centre in Taiwan, 2000-12
|
PO-REN HSUEH; PO-REN HSUEH;Tien H.-F.;Tsay W.;Tang J.-L.;Yao M.;Chou W.-C.;Huang S.-Y.;Sheng W.-H.;Chen C.-Y.; Chen C.-Y.; Sheng W.-H.; Huang S.-Y.; Chou W.-C.; Yao M.; Tang J.-L.; Tsay W.; Tien H.-F. |
| 臺大學術典藏 |
2020-03-09T06:08:11Z |
Use of Hypoprothrombinemia-Inducing Cephalosporins and the Risk of Hemorrhagic Events: A Nationwide Nested Case-Control Study
|
Chen L.-J.; Hsiao F.-Y.; Shen L.-J.; Wu F.-L.L.; Tsay W.; Hung C.-C.; SHU-WEN LIN |
| 臺大學術典藏 |
2020-03-07T06:42:16Z |
The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia
|
Chou W.-C. ;Lei W.-C. ;Ko B.-S. ;Hou H.-A. ;Chen C.-Y. ;Tang J.-L. ;Yao M. ;Tsay W. ;Wu S.-J. ;Huang S.-Y. ;Hsu S.-C. ;Chen Y.-C. ;Chang Y.-C. ;Kuan-Ting Kuo ;Lee F.-Y. ;Liu M.-C. ;Liu C.-W. ;Tseng M.-H. ;Huang C.-F. ;Tien H.-F.; Chou W.-C.; Lei W.-C.; Ko B.-S.; Hou H.-A.; Chen C.-Y.; Tang J.-L.; Yao M.; Tsay W.; Wu S.-J.; Huang S.-Y.; Hsu S.-C.; Chen Y.-C.; Chang Y.-C.; KUAN-TING KUO; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; Tien H.-F. |
| 臺大學術典藏 |
2020-03-07T06:42:14Z |
TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics
|
Chou W.-C.; Chou S.-C.; Liu C.-Y.; Chen C.-Y.; Hou H.-A.; Kuo Y.-Y.; Lee M.-C.; Ko B.-S.; Tang J.-L.; Yao M.; Tsay W.; Wu S.-J.; Huang S.-Y.; Hsu S.-C.; Chen Y.-C.; Chang Y.-C.; Kuo Y.-Y.; KUAN-TING KUO; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; Tien H.-F.; Chou W.-C. ;Chou S.-C. ;Liu C.-Y. ;Chen C.-Y. ;Hou H.-A. ;Kuo Y.-Y. ;Lee M.-C. ;Ko B.-S. ;Tang J.-L. ;Yao M. ;Tsay W. ;Wu S.-J. ;Huang S.-Y. ;Hsu S.-C. ;Chen Y.-C. ;Chang Y.-C. ;Kuo Y.-Y. ;Kuan-Ting Kuo ;Lee F.-Y. ;Liu M.-C. ;Liu C.-W. ;Tseng M.-H. ;Huang C.-F. ;Tien H.-F. |
| 臺大學術典藏 |
2020-03-05T07:52:38Z |
TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics
|
Chou W.-C.; Chou S.-C.; Liu C.-Y.; Chen C.-Y.; Hou H.-A.; Kuo Y.-Y.; Lee M.-C.; Ko B.-S.; Tang J.-L.; Yao M.; Tsay W.; Wu S.-J.; Huang S.-Y.; Hsu S.-C.; Chen Y.-C.; Chang Y.-C.; Kuo Y.-Y.; KUAN-TING KUO; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; Tien H.-F. |
